Retinal and optic nerve tissues are highly energy‑demanding. This page provides a cautious overview of how NAD+ and mitochondrial function are discussed in relation to cellular bioenergetics and ocular aging, without replacing clinical assessment or therapeutic decisions made by eye care specialists.
In age‑related chronic diseases, the eye is increasingly viewed through the lens of its continuous energy demand. NAD+ (Nicotinamide Adenine Dinucleotide) is a key cofactor in many metabolic reactions driving ATP production. Experimental and clinical studies have reported that tissue NAD+ levels decline with age, and this phenomenon is being investigated as one of several contributors to reduced bioenergetic efficiency in various tissues, including ocular structures. This remains an evolving research field and does not yet define standardized clinical protocols.
The side panels schematically represent factors that the literature discusses as potential “accelerators” or “brakes” of mitochondrial function. The animation is purely didactic and does not depict a quantitative physiological model.
The retina, especially photoreceptors, ranks among the most metabolically active tissues in the body. Proper mitochondrial function is essential to meet its ATP requirements. Age‑related mitochondrial decline is being studied as one of the elements that may contribute to ocular aging, without acting as a single determining cause.
Sirtuins are a family of NAD‑dependent enzymes involved in multiple cellular processes, including responses to oxidative stress and metabolic regulation. NAD+ availability influences their activity and has fuelled interest in how NAD+ metabolism, sirtuins and tissue aging interact. The clinical implications of these observations are still under investigation.
NAD+ participates in numerous steps of carbohydrate and lipid metabolism. A cell’s ability to flexibly switch between energy substrates is considered an aspect of its metabolic resilience. In ocular tissues, such flexibility may be relevant for adapting to varying energy demands, though this remains largely a physiopathological concept.
The energetic status of immune cells such as macrophages or microglia can influence how tissues handle debris and prolonged stress. Impaired bioenergetics could theoretically affect these dynamics, but the exact ways in which such mechanisms impact clinical ocular conditions are complex and not fully defined.
Preclinical models of neurodegeneration have explored interventions aimed at preserving or enhancing the cellular NAD+ pool to assess whether this might support neuronal survival. These are promising but still preliminary hypotheses; in real‑world patients, any consideration of metabolic support must be framed within available evidence and individual clinical context.
A tissue’s capacity to maintain appropriate cellular turnover over time is partly dependent on energy availability. In ocular aging, it is hypothesized that more efficient metabolism may help sustain maintenance and repair processes, while recognising that many genetic, environmental and systemic factors jointly shape clinical outcomes.
Explore additional systemic aspects related to visual well‑being.
The concepts described on this page refer mainly to biochemical and physiopathological mechanisms of NAD+ and mitochondrial function. Any nutritional or integrative strategies must, if considered, be discussed within an individualized clinical framework agreed upon with the general practitioner and ophthalmologist. The information provided does not constitute a therapeutic proposal, does not replace ophthalmic treatments and must not be used to autonomously modify medications or ongoing therapies.